Pharmacological Action of Mildronate

  • Author:Ray Dean
  • Source:www.oceanchinachem,com
  • Release on :2016-06-10

Mildronate is a structural analogue of carnitine, betaine could competitively inhibit acid hydroxylase, thereby inhibiting the biosynthesis of carnitine, direct inhibition of carnitine-dependent fatty acid transport in mitochondria. Inhibition of the biosynthesis of carnitine may reduce intracellular concentrations of free carnitine, prevent isoproterenol-induced accumulation of acyl carnitine. Therefore, this drug has significant myocardial protection role in this protective effect while producing no significant effect on the hemodynamic parameters, blood supply to the heart and cardiac oxygen consumption did not change.


Mildronate can reduce the accumulation of long chain acyl carnitine, carnitine-dependent fatty acid oxidation can be suppressed, so that the anoxic myocardial energy metabolism from fatty acid oxidation conversion to a more favorable glucose oxidase, namely to promote the glycolytic pathway anaerobic oxidation, so this product has anti-anoxia utility and cardioprotective activity. Furthermore, Meldonium can inhibit carnitine acetyltransferase, thus improving the utilization of various metabolic pathways in mitochondria to acetyl CAA, ATP and ADP concentration to prevent decline, and preventing the accumulation of AMP induced by isoproterenol and energy charge decreases play myocardial protection.


Hubei Ocean Biotech Co., Ltd, China pharmaceutical products and APIs supplier, with credible service and the honest management, we have gained good reputation at domestic and abroad market. Should you have any interest to our other products, please take a view at our site at site for more informations.